Issue of shares
09 November 2006 - 4:59AM
UK Regulatory
RNS Number:7905L
Healthcare Enterprise Group PLC
08 November 2006
8 November 2006
Healthcare Enterprise Group PLC
(the "Company")
Issue of shares
Firm Placing
Further to the announcement made on 2 November 2006, the Firm Placing (as
further described in such announcement) is now complete.
Accordingly 6,666,667 ordinary shares of 2.5 pence each in the Company
("Ordinary Shares") were admitted to trading on AIM this morning.
Of these shares, Directors of the Company or their connected persons subscribed
for 3,333,333 Ordinary Shares at 3 pence per share as follows:
Mr Lyndon Gaborit - 833,333
Mr Mark Tompkins - 833,333
Mr Nigel Wray - 1,666,667.
Non-Executive Directors Share Issues
In addition, in relation to the provision of services as non-executive
directors, the Company has allotted Ordinary Shares on 8 November 2006 (at the
mid-market closing price on 7 November 2006 of 3.38p per share) in satisfaction
of professional fees as follows:
Mr Nicholas Brigstocke - 133,136 Ordinary Shares in the Company
(at 3.38p per share);
Mr Mark Tompkins - 133,136 Ordinary Shares in the Company
(at 3.38p per share); and
Mr Nigel Wray - 133,136 Ordinary Shares in the Company
(at 3.38p per share).
The shares are expected to be admitted to trading on AIM on 15 November 2006.
Exercise of Options
In addition, the Company announces that a total of 1,520,681 new Ordinary Shares
have been issued and allotted, pursuant to the Company's share option scheme, on
8 November 2006.
The optionholders exercising options were as follows:
Mr Nicholas Brigstocke (a non-executive director of the Company) -
113,246 Ordinary Shares in the Company (at 2.5p per share);
Mr Ken Denos (formerly an executive director of the Company) -
199,476 Ordinary Shares in the Company (at 2.5p per share); and
Mr Michael Low (formerly an executive director of the Company) -
1,207,959 Ordinary Shares in the Company (at 2.5p per share).
The shares are expected to be admitted to trading on AIM on 15 November 2006.
Directors' Shareholdings
The resulting holdings of the Directors are as follows:
Director Overall Number of Percentage of issued share capital as enlarged
number of new Ordinary Shares by the Placing (assuming the shareholder
Ordinary held following resolutions at the EGM on 27 November are
Shares the Placing and passed and the Conditional Placing Shares, as
acquired shares issues further described in the 2 November
notified in this announcement, are all allotted)
announcement
Nicholas Brigstocke 246,382 2,072,186 0.76
Lyndon Gaborit 833,333 1,053,351 0.38
Mark Tompkins 966,469 1,274,409 0.47
Nigel Wray 1,799,803 17,222,057 6.32
Total 3,845,987 21,622,003 7.93
Fertiloscopy
Further to previous announcements about the restructuring and scaling back on
capital expenditure, the Group's decision not to proceed with the Fertiloscopy
project has resulted in the issue, on 8 November 2006, of 1,008,428 ordinary
shares of 2.5p each in the Company in respect of the closure of matters relating
to Fertiloscopy, at a (five preceding days mid-market closing) price of 3.322
pence per share.
The shares are expected to be admitted to trading on AIM on 15 November 2006.
Total Issued Share Capital
The Company's issued share capital at this time is 212,483,387 ordinary shares
of 2.5 pence each.
Conditional Placing and amendment to warrant terms
As set out in the announcement on 2 November 2006, a further 60,000,000 ordinary
shares have been placed on a conditional basis. Subsequent to that, the issued
share capital of the Company (subject to any further allotments) would be
272,483,387 Ordinary Shares.
The conditions include, among other things, the passing by shareholders at an
EGM to be held on 27 November 2006 of a resolution to give the Directors
authority to allot shares up to an agreed limit and to dis-apply statutory
pre-emption rights on allotments of shares.
As further described in the 2 November announcement, subject to the passing of
resolutions at the EGM and warrantholders meeting on 27 November, the Company
will allot warrants (on a 1 for 4 basis) to placees under the Placing, and amend
the terms of the existing warrants in issue.
Enquiries:
College Hill 020 7457 2020
Adrian Duffield / Corinna Dorward
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEDVLFBQFBEFBE
Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Jul 2023 to Jul 2024